Jacobs Levy Equity Management Portfolio holdings
AUM
$25.5B
1-Year Return
20.81%
This Quarter Return
+1.43%
1 Year Return
+20.81%
3 Year Return
+97.14%
5 Year Return
+210.43%
10 Year Return
+444.59%
AUM
$6.01B
AUM Growth
+$319M
(+5.6%)
Cap. Flow
+$264M
Cap. Flow
% of AUM
4.4%
Top 10 Holdings %
Top 10 Hldgs %
12.12%
Holding
1,131
New
156
Increased
425
Reduced
373
Closed
144
Top Buys
| 1 |
Microsoft
MSFT
|
$34.7M |
| 2 |
Cigna
CI
|
$27.5M |
| 3 |
UnitedHealth
UNH
|
$24.7M |
| 4 |
AutoZone
AZO
|
$22.1M |
| 5 |
Eli Lilly
LLY
|
$20.9M |
Top Sells
| 1 |
Exxon Mobil
XOM
|
$32.6M |
| 2 |
XL
XL Group Ltd.
XL
|
$25.4M |
| 3 |
RHT
Red Hat Inc
RHT
|
$23.8M |
| 4 |
McKesson
MCK
|
$23.4M |
| 5 |
Progressive
PGR
|
$17.5M |
Sector Composition
| 1 | Technology | 19.15% |
| 2 | Financials | 18.28% |
| 3 | Industrials | 13.51% |
| 4 | Consumer Discretionary | 11.12% |
| 5 | Healthcare | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MACK
826
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $372K | 0.01% |
58,727
+32,799
| +127% | +$208K |
|
827
Amgen
AMGN
$153B
| $370K | 0.01% |
+2,172
| New | +$370K |
|
828
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $370K | 0.01% |
+33,506
| New | +$370K |
|
829
Rocky Brands
RCKY
$217M
| $370K | 0.01% |
17,250
-6,553
| -28% | -$141K |
|
830
Globus Medical
GMED
$8.18B
| $369K | 0.01% |
+7,400
| New | +$369K |
|
|
CALA
831
DELISTED
Calithera Biosciences, Inc
CALA
| $368K | 0.01% |
2,923
+1,995
| +215% | +$251K |
|
832
Crown Holdings
CCK
$11B
| $366K | 0.01% |
7,220
-540
| -7% | -$27.4K |
|
833
Covenant Logistics
CVLG
$599M
| $366K | 0.01% |
24,510
-200
| -0.8% | -$2.99K |
|
834
Ryerson Holding
RYI
$757M
| $366K | 0.01% |
44,962
+24,906
| +124% | +$203K |
|
|
TBNK
835
DELISTED
Territorial Bancorp Inc.
TBNK
| $364K | 0.01% |
12,282
+400
| +3% | +$11.9K |
|
836
Movado Group
MOV
$431M
| $362K | 0.01% |
9,431
| – | – |
|
|
DWCH
837
DELISTED
Datawatch Corp
DWCH
| $353K | 0.01% |
40,776
-27,962
| -41% | -$242K |
|
838
Zevra Therapeutics
ZVRA
$502M
| $350K | 0.01% |
2,765
-609
| -18% | -$77.1K |
|
|
TCON
839
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $348K | 0.01% |
757
+323
| +74% | +$148K |
|
840
Union Pacific
UNP
$131B
| $347K | 0.01% |
2,580
+860
| +50% | +$116K |
|
|
SAGE
841
DELISTED
Sage Therapeutics
SAGE
| $346K | 0.01% |
+2,150
| New | +$346K |
|
|
BDSI
842
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $346K | 0.01% |
153,970
-216,246
| -58% | -$486K |
|
|
UPL
843
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
| $344K | 0.01% |
82,400
-178,000
| -68% | -$743K |
|
|
JNP
844
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $340K | 0.01% |
33,501
-5,800
| -15% | -$58.9K |
|
845
Larimar Therapeutics
LRMR
$337M
| $339K | 0.01% |
3,797
-567
| -13% | -$50.6K |
|
846
Ezcorp Inc
EZPW
$1.02B
| $338K | 0.01% |
25,600
+8,500
| +50% | +$112K |
|
847
Halliburton
HAL
$18.8B
| $337K | 0.01% |
7,180
-2,120
| -23% | -$99.5K |
|
848
Amtech Systems
ASYS
$91.9M
| $333K | 0.01% |
45,555
-55,578
| -55% | -$406K |
|
|
CAI
849
DELISTED
CAI International, Inc.
CAI
| $333K | 0.01% |
15,640
-10,600
| -40% | -$226K |
|
|
BAS
850
DELISTED
Basis Energy Services, Inc.
BAS
| $332K | 0.01% |
23,000
+11,400
| +98% | +$165K |
|